{"count": 15, "results": [{"_id": "32316910", "pmid": 32316910, "pmcid": "PMC7175536", "title": "Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention", "journal": "BMC Cardiovasc Disord", "authors": ["Yu Q", "Zhu JJ", "Liu WX"], "date": "2020-04-21T00:00:00Z", "doi": "10.1186/s12872-020-01474-5", "meta_date_publication": "2020 Apr 21", "meta_volume": "20", "meta_issue": "1", "meta_pages": "187", "score": 50272.56, "text_hl": "The GIPS III trial has supported the idea that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is safe to use after @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@ and contrast agent exposure. ", "citations": {"NLM": "Yu Q, Zhu JJ, Liu WX. Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention BMC Cardiovasc Disord. 2020 Apr 21;20(1):187. PMID: 32316910", "BibTeX": "@article{32316910, title={Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention}, author={Yu Q and Zhu JJ and Liu WX}, journal={BMC Cardiovasc Disord}, volume={20}, number={1}, pages={187}}"}}, {"_id": "37196121", "pmid": 37196121, "pmcid": "PMC10529738", "title": "Acute, High Dose Metformin Therapy at Reperfusion Decreases Infarct Size in the High-Risk Aging Heart", "journal": "Aging Dis", "authors": ["Bates L", "Krause-Hauch M", "Wang H", "Fatmi MK", "Li Z", "Chen Q", "Ren D", "Li J", "Lesnefsky EJ"], "date": "2023-03-01T00:00:00Z", "doi": "10.14336/AD.2023.0205", "meta_date_publication": "2023 Mar 1", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.023, "text_hl": "The administration of high dose @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the setting of @SPECIES_9606 @@@human@@@ @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@ is potentially feasible. ", "citations": {"NLM": "Bates L, Krause-Hauch M, Wang H, Fatmi MK, Li Z, Chen Q, Ren D, Li J, Lesnefsky EJ. Acute, High Dose Metformin Therapy at Reperfusion Decreases Infarct Size in the High-Risk Aging Heart Aging Dis. 2023 Mar 1;():. PMID: 37196121", "BibTeX": "@article{37196121, title={Acute, High Dose Metformin Therapy at Reperfusion Decreases Infarct Size in the High-Risk Aging Heart}, author={Bates L and Krause-Hauch M and Wang H and Fatmi MK and Li Z and Chen Q and Ren D and Li J and Lesnefsky EJ}, journal={Aging Dis}}"}}, {"_id": "34593124", "pmid": 34593124, "title": "Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.", "journal": "J Am Coll Cardiol", "authors": ["de Koning MLY", "Westenbrink BD", "Assa S", "Garcia E", "Connelly MA", "van Veldhuisen DJ", "Dullaart RPF", "Lipsic E", "van der Harst P"], "date": "2021-10-05T00:00:00Z", "doi": "10.1016/j.jacc.2021.07.054", "meta_date_publication": "2021 Oct 5", "meta_volume": "78", "meta_issue": "14", "meta_pages": "1421-1432", "score": 50253.176, "text_hl": "METHODS: @CHEMICAL_Ketone_Bodies @CHEMICAL_MESH:D007657 @@@KBs@@@ were measured in 369 participants from a randomized trial on early @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy after @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@. ", "citations": {"NLM": "de Koning MLY, Westenbrink BD, Assa S, Garcia E, Connelly MA, van Veldhuisen DJ, Dullaart RPF, Lipsic E, van der Harst P. Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2021 Oct 5;78(14):1421-1432. PMID: 34593124", "BibTeX": "@article{34593124, title={Association of Circulating Ketone Bodies With Functional Outcomes After ST-Segment Elevation Myocardial Infarction.}, author={de Koning MLY and Westenbrink BD and Assa S and Garcia E and Connelly MA and van Veldhuisen DJ and Dullaart RPF and Lipsic E and van der Harst P}, journal={J Am Coll Cardiol}, volume={78}, number={14}, pages={1421-1432}}"}}, {"_id": "37517783", "pmid": 37517783, "title": "Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.", "journal": "Int J Cardiol", "authors": ["de Koning MLY", "Al Ali L", "Bourgonje AR", "Assa S", "Pasch A", "van Goor H", "Lipsic E", "van der Harst P"], "date": "2023-07-28T00:00:00Z", "doi": "10.1016/j.ijcard.2023.131214", "meta_date_publication": "2023 Jul 28", "meta_volume": "", "meta_issue": "", "meta_pages": "131214", "score": 50251.363, "text_hl": "METHODS: FTs were detected in archived serum samples from 378 participants of a neutral randomized trial on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy after @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@. ", "citations": {"NLM": "de Koning MLY, Al Ali L, Bourgonje AR, Assa S, Pasch A, van Goor H, Lipsic E, van der Harst P. Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction. Int J Cardiol. 2023 Jul 28;():131214. PMID: 37517783", "BibTeX": "@article{37517783, title={Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.}, author={de Koning MLY and Al Ali L and Bourgonje AR and Assa S and Pasch A and van Goor H and Lipsic E and van der Harst P}, journal={Int J Cardiol}, pages={131214}}"}}, {"_id": "22968678", "pmid": 22968678, "pmcid": "PMC3464381", "title": "Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial", "journal": "Cardiovasc Drugs Ther", "authors": ["Lexis CP", "van der Horst IC", "Lipsic E", "van der Harst P", "van der Horst-Schrivers AN", "Wolffenbuttel BH", "de Boer RA", "van Rossum AC", "van Veldhuisen DJ", "de Smet BJ", "GIPS-III Investigators"], "date": "2012-10-01T00:00:00Z", "doi": "10.1007/s10557-012-6413-1", "meta_date_publication": "2012 Oct", "meta_volume": "26", "meta_issue": "5", "meta_pages": "417-26", "score": 50069.227, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in non-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetic@@@ @SPECIES_9606 @@@Patients@@@ Presenting with @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST Elevation Myocardial Infarction@@@: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST Elevation Myocardial Infarction@@@ (GIPS)-III Trial", "citations": {"NLM": "Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ, GIPS-III Investigators. Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. PMID: 22968678", "BibTeX": "@article{22968678, title={Metformin in non-Diabetic Patients Presenting with ST Elevation Myocardial Infarction: Rationale and Design of the Glycometabolic Intervention as Adjunct to Primary Percutaneous Intervention in ST Elevation Myocardial Infarction (GIPS)-III Trial}, author={Lexis CP and van der Horst IC and Lipsic E and van der Harst P and van der Horst-Schrivers AN and Wolffenbuttel BH and de Boer RA and van Rossum AC and van Veldhuisen DJ and de Smet BJ and GIPS-III Investigators}, journal={Cardiovasc Drugs Ther}, volume={26}, number={5}, pages={417-26}}"}}, {"_id": "27977774", "pmid": 27977774, "pmcid": "PMC5158040", "title": "The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction", "journal": "PLoS One", "authors": ["Al Ali L", "Hartman MT", "Lexis CP", "Hummel YM", "Lipsic E", "van Melle JP", "van Veldhuisen DJ", "Voors AA", "van der Horst IC", "van der Harst P"], "date": "2016-12-15T00:00:00Z", "doi": "10.1371/journal.pone.0168340", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "12", "meta_pages": "e0168340", "score": 50067.17, "text_hl": "The Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on Diastolic Function in @SPECIES_9606 @@@Patients@@@ Presenting with @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-Elevation Myocardial Infarction@@@", "citations": {"NLM": "Al Ali L, Hartman MT, Lexis CP, Hummel YM, Lipsic E, van Melle JP, van Veldhuisen DJ, Voors AA, van der Horst IC, van der Harst P. The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction PLoS One. 2016;11(12):e0168340. PMID: 27977774", "BibTeX": "@article{27977774, title={The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction}, author={Al Ali L and Hartman MT and Lexis CP and Hummel YM and Lipsic E and van Melle JP and van Veldhuisen DJ and Voors AA and van der Horst IC and van der Harst P}, journal={PLoS One}, volume={11}, number={12}, pages={e0168340}}"}}, {"_id": "26808474", "pmid": 26808474, "pmcid": "PMC4726568", "title": "Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial", "journal": "PLoS One", "authors": ["Eppinga RN", "Hartman MH", "van Veldhuisen DJ", "Lexis CP", "Connelly MA", "Lipsic E", "van der Horst IC", "van der Harst P", "Dullaart RP"], "date": "2016-01-25T00:00:00Z", "doi": "10.1371/journal.pone.0145719", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "1", "meta_pages": "e0145719", "score": 50057.484, "text_hl": "We determined whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration affects lipoprotein subfractions 4 months after @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-segment elevation MI@@@ (@<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@). ", "citations": {"NLM": "Eppinga RN, Hartman MH, van Veldhuisen DJ, Lexis CP, Connelly MA, Lipsic E, van der Horst IC, van der Harst P, Dullaart RP. Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial PLoS One. 2016;11(1):e0145719. PMID: 26808474", "BibTeX": "@article{26808474, title={Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial}, author={Eppinga RN and Hartman MH and van Veldhuisen DJ and Lexis CP and Connelly MA and Lipsic E and van der Horst IC and van der Harst P and Dullaart RP}, journal={PLoS One}, volume={11}, number={1}, pages={e0145719}}"}}, {"_id": "27376570", "pmid": 27376570, "title": "Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.", "journal": "Int J Cardiol", "authors": ["Zeller M", "Labalette-Bart M", "Juliard JM", "Potier L", "Feldman LJ", "Steg PG", "Cottin Y", "Roussel R"], "date": "2016-10-01T00:00:00Z", "doi": "10.1016/j.ijcard.2016.06.076", "meta_date_publication": "2016 Oct 1", "meta_volume": "220", "meta_issue": "", "meta_pages": "137-42", "score": 50053.973, "text_hl": "AIM: To analyze the association between chronic @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment and the development of @DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@contrast-induced acute kidney injury@@@ (@DISEASE_Acute_Kidney_Injury @DISEASE_MESH:D058186 @@@CI-AKI@@@) after primary percutaneous coronary intervention (PCI) for @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST segment elevation myocardial infarction@@@ (@<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@). ", "citations": {"NLM": "Zeller M, Labalette-Bart M, Juliard JM, Potier L, Feldman LJ, Steg PG, Cottin Y, Roussel R. Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study. Int J Cardiol. 2016 Oct 1;220():137-42. PMID: 27376570", "BibTeX": "@article{27376570, title={Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study.}, author={Zeller M and Labalette-Bart M and Juliard JM and Potier L and Feldman LJ and Steg PG and Cottin Y and Roussel R}, journal={Int J Cardiol}, volume={220}, pages={137-42}}"}}, {"_id": "25959758", "pmid": 25959758, "title": "[Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].", "journal": "G Ital Cardiol (Rome)", "authors": ["Paneni F", "Costantino S", "Cosentino F"], "date": "2015-04-01T00:00:00Z", "doi": "10.1714/1848.20186", "meta_date_publication": "2015 Apr", "meta_volume": "16", "meta_issue": "4", "meta_pages": "225-31", "score": 50053.906, "text_hl": "In @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-@@@elevation @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (@<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@), retrospective analyses showed that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is associated with reduced @DISEASE_Infarction @DISEASE_MESH:D007238 @@@infarct@@@ size as compared to non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-based strategies, implicating beneficial effects beyond @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ control. ", "citations": {"NLM": "Paneni F, Costantino S, Cosentino F. [Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications]. G Ital Cardiol (Rome). 2015 Apr;16(4):225-31. PMID: 25959758", "BibTeX": "@article{25959758, title={[Metformin and left ventricular remodeling after acute myocardial infarction: molecular mechanisms and clinical implications].}, author={Paneni F and Costantino S and Cosentino F}, journal={G Ital Cardiol (Rome)}, volume={16}, number={4}, pages={225-31}}"}}, {"_id": "27656713", "pmid": 27656713, "pmcid": "PMC4636992", "title": "Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial", "journal": "Cardiovasc Drugs Ther", "authors": ["Posma RA", "Lexis CP", "Lipsic E", "Nijsten MW", "Damman K", "Touw DJ", "van Veldhuisen DJ", "van der Harst P", "van der Horst IC"], "date": "2015-01-01T00:00:00Z", "doi": "10.1007/s10557-015-6618-1", "meta_date_publication": "2015", "meta_volume": "29", "meta_issue": "5", "meta_pages": "451-9", "score": 50053.297, "text_hl": "The association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and renal function needs further to be elucidated since data are insufficient whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ affects renal function in higher risk populations such as after @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-elevation myocardial infarction@@@ (@<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@STEMI@@@).", "citations": {"NLM": "Posma RA, Lexis CP, Lipsic E, Nijsten MW, Damman K, Touw DJ, van Veldhuisen DJ, van der Harst P, van der Horst IC. Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial Cardiovasc Drugs Ther. 2015;29(5):451-9. PMID: 27656713", "BibTeX": "@article{27656713, title={Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial}, author={Posma RA and Lexis CP and Lipsic E and Nijsten MW and Damman K and Touw DJ and van Veldhuisen DJ and van der Harst P and van der Horst IC}, journal={Cardiovasc Drugs Ther}, volume={29}, number={5}, pages={451-9}}"}}]}